Nektar Therapeutics (NKTR) Tops Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Nektar Therapeutics (NKTR) PT Lowered to $86 at Cowen
August 9, 2018 7:41 AM EDTCowen lowered its price target on Nektar Therapeutics (NASDAQ: NKTR) to $86.00 (from $101.00) while maintaining a Outperform rating.
... More


